a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

Khuri, F R; Nemunaitis, J; Ganly, I; Arseneau, J; Tannock, I F; Romel, L; Gore, M; Ironside, J; MacDougall, R H; Heise, C; Randlev, B; Gillenwater, A M; Bruso, P; Kaye, S B; Hong, W K; Kirn, D H

Khuri, F R; Nemunaitis, J; Ganly, I; Arseneau, J; Tannock, I F; Romel, L; Gore, M; Ironside, J; MacDougall, R H; Heise, C; Randlev, B; Gillenwater, A M; Bruso, P; Kaye, S B; Hong, W K; Kirn, D H.

Affiliation

Khuri FR; The University of Texas M. D. Anderson Cancer Center, Division of Cancer Medicine, Houston, Texas, USA.

Nat Med ; 6(8): 879-85, 2000 Aug.

Article in En | MEDLINE | ID: mdl-10932224

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Adenoviruses, Human / Cisplatin / Fluorouracil / Head and Neck Neoplasms / Neoplasm Recurrence, Local Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2000 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links